Original Article
Modern Pathology (2004) 17, 49–55, advance online publication, 19 November 2003; doi:10.1038/modpathol.3800011
Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications
A Driessen1, P Nafteux2, T Lerut2, D Van Raemdonck2, P De Leyn2, L Filez3, F Penninckx3, K Geboes4 and N Ectors4
- 1Department of Pathology, University Hospital Maastricht, The Netherlands
- 2Department of Thoracic Surgery, University Hospitals Leuven, Belgium
- 3Department of Abdominal Surgery, University Hospitals Leuven, Belgium
- 4Department of Pathology, University Hospitals Leuven, Belgium
Correspondence: A Driessen, Department of Pathology, University Hospital Maastricht, P Debyelaan 25 Postbus 5800, AZ 6202 Maastricht, The Netherlands. E-mail: adri@lpat.azm.nl
Received 28 July 2003; Revised 4 September 2003; Accepted 5 October 2003; Published online 19 November 2003.
Abstract
Surgical treatment and prognosis is different in esophageal, cardiac and distal gastric adenocarcinomas. Determination of the origin, in particular of adenocarcinomas situated at the gastroesophageal junction, may be difficult. It has been suggested that esophageal adenocarcinomas are characterized by a specific cytokeratin pattern, namely the CK7+/CK20- pattern. According to the same authors, this cytokeratin pattern is absent in gastric adenocarcinomas. The aim of our study is to evaluate if this cytokeratin pattern CK7+/CK20- is absent in cardiac and distal gastric adenocarcinomas. Therefore, we evaluated the combined immunohistochemical expression of CK7 and CK20 on paraffin-embedded material of 214 resection specimens for adenocarcinoma, comprising 66 esophageal, 73 cardiac and 75 distal gastric adenocarcinomas (UICC-classification). The adenocarcinomas were subtyped into intestinal- and diffuse-type according to the Lauren classification. The immunohistochemical staining was considered as positive if 50% or more of the tumor cells were stained. Statistical analysis has been performed applying the
2-test. The tumors situated at the gastroesophageal junction, esophageal as well as cardiac adenocarcinomas, showed predominantly a CK7+/CK20- expression pattern (67 vs 68%), whereas this cytokeratin pattern is rather uncommon in distal gastric adenocarcinomas (31%, P<4
10-5). Independent of their localization, intestinal- as well as diffuse-type adenocarcinomas have a similar cytokeratin pattern. Our data show that the combined expression of CK7 and CK20 is different for the adenocarcinomas situated on both sides of the gastroesophageal junction compared to the distal gastric adenocarcinomas. However, in contrast to data in the literature, the combined expression of CK7 and CK20 has a low specificity in the distinction between esophageal and cardiac adenocarcinomas. This may suggest a similar origin (cell lineage) and thus may have an impact on therapeutic strategies.
Keywords:
cytokeratins, gastric adenocarcinoma, esophageal adenocarcinoma, cardiac adenocarcinoma
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Barrett esophagus: histology and pathology for the clinician
Nature Reviews Gastroenterology & Hepatology Review (01 Aug 2009)
RESEARCH
Intestinal metaplasia at the gastroesophageal junction: Barrett?s, bacteria, and biomarkers
American Journal of Gastroenterology Correspondence
Phenotypic differences between esophageal and gastric intestinal metaplasia
Modern Pathology Original Article
Modern Pathology Original Article
Laboratory Investigation Research Article

